Format

Send to

Choose Destination
See comment in PubMed Commons below
Psychopharmacology (Berl). 2000 May;150(1):120-2.

Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine.

Author information

  • 1University Department of Psychiatry, Warneford Hospital, Oxford, UK.

Abstract

RATIONALE:

A 44-base-pair insertion/deletion polymorphism in the promoter region of the human serotonin (5-HT) transporter (5-HTT) gene gives rise to a bi-allelic polymorphism designated long (l) and short (s). The s variant is associated with a lower expression of 5-HTT sites and a reduced efficiency of 5-HT reuptake.

OBJECTIVE:

The aim of the present study was to determine whether the increase in brain 5-HT function produced by acute 5-HT reuptake blockade is influenced by the 5-HTT promoter l/s polymorphism.

METHODS:

We measured the increase in plasma prolactin that follows acute administration of the tricyclic antidepressant clomipramine as an index of 5-HT neurotransmission in 14 healthy female subjects (7 with ss genotype and 7 with ll genotype) using a placebo-controlled crossover design.

RESULTS:

Clomipramine-induced prolactin release was significantly greater in subjects with the ll genotype.

CONCLUSION:

Our findings suggest that acute 5-HT reuptake blockade produces a greater increase in 5-HT neurotransmission in subjects with the ll genotype than in those with an ss genotype. These results are consistent with clinical data indicating that subjects with an ss genotype may have a poorer therapeutic response to selective serotonin reuptake inhibitor (SSRI) monotherapy.

PMID:
10867985
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk